Hospira Gemcitabine Injection (38 mg/mL) 200 mg/5.26 mL (US)

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

gemcitabine hydrochloride, Quantity: 43.27 mg/mL; water for injections

Pieejams no:

Hospira Australia Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

Gemcitabine hydrochloride,water for injections

Zāļu forma:

Injection, solution

Kompozīcija:

Excipient Ingredients: sodium hydroxide; hydrochloric acid

Ievadīšanas:

Intravenous Infusion

Vienības iepakojumā:

1 x 5.26 mL pack

Klase:

Medicine Listed (Export Only)

Receptes veids:

(S1) This Schedule is intentionally blank

Ārstēšanas norādes:

Ovarian cancer, breast cancer, non small cell lung cancer, pancreatic cancer

Produktu pārskats:

Visual Identification: A clear, colourless or light straw coloured solution practically free from visible particles; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Child resistant closure and restricted flow insert

Autorizācija statuss:

Licence status A

Autorizācija datums:

2011-11-04